LMB In The News

LMB is one of 12 of the UK’s leading universities and research institutions, across all 4 nations, selected to deliver the Global Talent Fund: a £54 million investment in Britain’s future prosperity and economic growth. More…

The Naked Scientists podcast covers all things protein, including speaking to Alan Fersht and Wes Robertson from the LMB’s PNAC Division. They cover how early advances at the LMB revolutionised the field of protein studies, and how protein design could be developed to address key concerns in health and the environment. More…

In 2013, Roger Williams’s group in the LMB’s PNAC Division published findings from a study conducted with researchers at the University of Cambridge, the Babraham Institute and clinicians from Addenbrooke’s Hospital. Together, the team identified a rare genetic mutation which causes a condition now known as Activated PI3K-d Syndrome (APDS), which weakens the immune system […]

Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…

Business Weekly reports that Constructive.Bio, an LMB spinout company based on Jason Chin’s research, now holds the exclusive licence to ‘tRNA Display’ technology. The company can start a full commercial rollout of its platform – enabling next-gen synthetic protein engineering applications for pharma, agriculture and advanced materials. More…

Anne Bertolotti, Group Leader and Joint Head of the LMB’s Neurobiology Division, has been announced as the 2025 recipient of the Jubilee Award Lecture from the International Union of Biochemistry and Molecular Biology (IUBMB) in recognition of her research on protein quality control mechanisms. More…